Works matching DE "CELGENE Corp."
Results: 34
A third quarter improvement for biotech hiring.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 11, p. 1056, doi. 10.1038/nbt1109-1056
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 11, doi. 10.1038/nbt0108-11
- By:
- Publication type:
- Article
Celgene buys Signal.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 8, p. 809, doi. 10.1038/78335
- By:
- Publication type:
- Article
Market watch.
- Published in:
- Nature, 2006, v. 444, n. 7117, p. 257, doi. 10.1038/444257b
- Publication type:
- Article
Therapeutics: Silencing psoriasis.
- Published in:
- Nature, 2012, v. 492, n. 7429, p. S58, doi. 10.1038/492S58a
- By:
- Publication type:
- Article
Deal watch: Celgene bets big on Scripps-originated autoimmunity candidate.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 9, p. 595, doi. 10.1038/nrd4716
- By:
- Publication type:
- Article
Built-to-buy start-ups begin to bloom.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 161, doi. 10.1038/nrd4258
- By:
- Publication type:
- Article
Trial watch: PDE4 inhibitor leads wave of target-specific oral psoriasis drugs.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 335, doi. 10.1038/nrd4017
- By:
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 264
- Publication type:
- Article
News.
- Published in:
- Textile Chemist & Colorist, 1986, v. 18, n. 10, p. 6
- Publication type:
- Article
Celanese Controls New Biotechnology Company.
- Published in:
- Textile Chemist & Colorist, 1986, v. 18, n. 10, p. 7
- Publication type:
- Article
A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach.
- Published in:
- Oncology & Therapy, 2020, v. 8, n. 1, p. 91, doi. 10.1007/s40487-019-0097-7
- By:
- Publication type:
- Article
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis.
- Published in:
- Annals of Internal Medicine, 2012, v. 157, n. 6, p. 398, doi. 10.7326/0003-4819-157-6-201209180-00003
- By:
- Publication type:
- Article
Lenalidomide Plus Low-Dose Dexamethasone Produces Survival Advantage in Multiple Myeloma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 5, p. 616
- Publication type:
- Article
ODAC Recommends Lenalidomide for Full Approval in Select MDS Patients.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 11, p. 1
- Publication type:
- Article
Recent cases highlight shortcomings and inconsistencies in the law: In re Ciprofloxacin; Celgene v. KV and SB Pharmco v. Mutual.
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 2, p. 167, doi. 10.1057/jgm.2008.37
- By:
- Publication type:
- Article
Deal watch: Epizyme-Celgene deal signals interest in new class of epigenetic drugs.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 508, doi. 10.1038/nrd3772
- By:
- Publication type:
- Article
Deal watch: Celgene acquires Gloucester pharmaceuticals, gaining approved HDAC inhibitor.
- Published in:
- 2010
- Publication type:
- journal article
Hematology/Oncology Tumor Board: Challenges in Nursing Management of Emerging Therapies for Hematologic Malignancies.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
Straight talk with...Patrick Soon-Shiong.
- Published in:
- Nature Medicine, 2012, v. 18, n. 2, p. 187, doi. 10.1038/nm0212-187
- By:
- Publication type:
- Article
SURVIVAL OVERWALL.
- Published in:
- Value-Based Cancer Care, 2017, v. 8, n. 5, p. 2
- Publication type:
- Article
Celgene Patient Support Services.
- Published in:
- 2018
- Publication type:
- Product Review
Dexmethylphenidate - Novartis/Celgene: Focalin™, D-MPH, D-Methylphenidate Hydrochloride, D-Methylphenidate, Dexmethylphenidate, Dexmethylphenidate Hydrochloride.
- Published in:
- Drugs in R&D, 2002, v. 3, n. 4, p. 279
- Publication type:
- Article
PBS listing for Revlimid.
- Published in:
- 2013
- Publication type:
- Product Review
Thalidomide trial for diarrhea.
- Published in:
- AIDS Patient Care & STDs, 1996, v. 10, n. 4, p. 263
- Publication type:
- Article
Arterial thrombosis in four patients treated with thalidomide.
- Published in:
- Leukemia & Lymphoma, 2005, v. 46, n. 2, p. 239, doi. 10.1080/10428190400015675
- By:
- Publication type:
- Article
Drug makers target ubiquitin proteasome pathway anew.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 11, p. 1115, doi. 10.1038/nbt1115-1115
- By:
- Publication type:
- Article
Celgene samples from science smorgasbord.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 9, p. 892, doi. 10.1038/nbt0915-892
- By:
- Publication type:
- Article
Celgene wagers on Sutro's cell-free platform to ramp up ADCs.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 12, p. 1175, doi. 10.1038/nbt1214-1175
- By:
- Publication type:
- Article
Celgene shells out for antisense drug.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 605, doi. 10.1038/nbt0714-605b
- By:
- Publication type:
- Article
First PDE4 inhibitor for psoriasis hits the market but impact is uncertain.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 6, p. 505, doi. 10.1038/nbt0614-505
- By:
- Publication type:
- Article
Third-quarter biotech job picture.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 11, p. 1149, doi. 10.1038/nbt.2417
- By:
- Publication type:
- Article
Companies in rapid pursuit of Btk immunokinase.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 3, p. 199, doi. 10.1038/nbt0312-199
- By:
- Publication type:
- Article
Business Digest.
- Published in:
- Chemistry & Industry, 2012, v. 76, n. 3, p. 15, doi. 10.1002/cind.7603_4.x
- Publication type:
- Article